-
EP4056043
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4056043
| EP4056043 - COMPOSITIONS AND METHODS OF BDNF ACTIVATION [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 24.02.2023 Database last updated on 14.06.2024 | |
| Former | The application has been published Status updated on 12.08.2022 | Most recent event Tooltip | 28.03.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states VDF Futureceuticals, Inc. 2692 N. State Route 1-17 Momence, Illinois 60954 / US | [2022/37] | Inventor(s) | 01 /
PIETRZKOWSKI, Zbigniew Aliso Viejo / US | [2022/37] | Representative(s) | Hutter, Anton Venner Shipley LLP 5 Stirling House Stirling Road The Surrey Research Park Guildford GU2 7RF / GB | [2022/37] | Application number, filing date | 22164560.9 | 14.03.2014 | [2022/37] | Priority number, date | US201361794452P | 15.03.2013 Original published format: US 201361794452 P | [2022/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP4056043 | Date: | 14.09.2022 | Language: | EN | [2022/37] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 16.08.2022 | Classification | IPC: | A23F5/00, A23L33/105, A61K36/74 | [2022/37] | CPC: |
A61K36/185 (EP,US);
A61K36/74 (US);
A23L19/01 (EP,US);
A23L33/105 (EP,US);
A61K31/352 (EP,US);
A61K9/0053 (US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/13] |
| Former [2022/37] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR AKTIVIERUNG VON BDNF | [2022/37] | English: | COMPOSITIONS AND METHODS OF BDNF ACTIVATION | [2022/37] | French: | COMPOSITIONS ET PROCÉDÉS D'ACTIVATION DE BDNF | [2022/37] | Examination procedure | 23.02.2023 | Amendment by applicant (claims and/or description) | 23.02.2023 | Examination requested [2023/13] | 23.02.2023 | Date on which the examining division has become responsible | Parent application(s) Tooltip | EP14764390.2 / EP2967102 | EP20168540.1 / EP3738439 | Fees paid | Renewal fee | 25.03.2022 | Renewal fee patent year 03 | 25.03.2022 | Renewal fee patent year 04 | 25.03.2022 | Renewal fee patent year 05 | 25.03.2022 | Renewal fee patent year 06 | 25.03.2022 | Renewal fee patent year 07 | 25.03.2022 | Renewal fee patent year 08 | 25.03.2022 | Renewal fee patent year 09 | 27.03.2023 | Renewal fee patent year 10 | 27.03.2024 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]US2010080885 (MILJKOVIC DUSAN [US], et al) [X] 1-14* figure 3; claims 1-19 *; | [X] - TANIA REYES-IZQUIERDO ET AL, "Modulatory effect of coffee fruit extract on plasma levels of brain-derived neurotrophic factor in healthy subjects", BRITISH JOURNAL OF NUTRITION, (20130114), vol. 110, no. 03, doi:10.1017/S0007114512005338, ISSN 0007-1145, pages 420 - 425, XP055282155 [X] 1-14 * the whole document * DOI: http://dx.doi.org/10.1017/S0007114512005338 | [XP] - TANIA REYES-IZQUIERDO ET AL, "Stimulatory Effect of Whole Coffee Fruit Concentrate Powder on Plasma Levels of Total and Exosomal Brain-Derived Neurotrophic Factor in Healthy Subjects: An Acute Within-Subject Clinical Study", FOOD AND NUTRITION SCIENCES, (20130901), vol. 04, no. 09, doi:10.4236/fns.2013.49127, ISSN 2157-944X, pages 984 - 990, XP055553893 [XP] 1-14 * abstract * DOI: http://dx.doi.org/10.4236/fns.2013.49127 | by applicant | US7754263 | US7807205 | US7815959 | US8597710 | US8603564 | US8603563 | - Molecular Therapy, (20111000), vol. 19, no. 10, pages 1769 - 1779 | - Nanomedicine, (20120000), vol. 7, no. 8, pages 1225 - 1233 | - Therapeutic Delivery, (20110000), vol. 2, no. 9, pages 1095 - 1099 | - Advanced Drug Delivery Reviews, (20120000), vol. 65, no. 3, pages 342 - 347 | - Journal of Controlled Release, (20120000), vol. 161, no. 2, pages 635 - 644 |